clinical 1,382 words KG: Diagnosing Frontotemporal Lobar Degeneration (NCT02964637) 2026-03-24
kind:clinical-trialsection:clinical-trialsstate:publishedftldftdbiomarkersdiagnosisneuroimaginggenetics
Contents

Diagnosing Frontotemporal Lobar Degeneration (NCT02964637)

Knowledge Graph

Related Hypotheses (14)

Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.60
Cryptic Exon Silencing Restoration
Score: 0.54
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.69
Competitive APOE4 Domain Stabilization Peptides
Score: 0.66
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.63

Related Analyses (2)

RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived

Related Experiments (12)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90
Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80
s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40

Knowledge Graph (3 edges)

Diagnosing Frontotemporal Lobar Degeneration (NCT02964637) references APOE
Diagnosing Frontotemporal Lobar Degeneration (NCT02964637) references VCP
Diagnosing Frontotemporal Lobar Degeneration (NCT02964637) references TARDBP